article thumbnail

The Financialization of Disruptive Technology

The Agile Manager

A recent FT Lex article on biotech investing drives the point home: "A 20-year study found only one-fifth of exits were profitable. This took advantage of a unique characteristics of software vis-a-vis its industrial (hardware) predecessors: real-time adaptability. Investment yields are highly concentrated. Picking winners is hard.